Table 2

Prevalence and demography of resistance

CPE MRSA VRE ESBL Colonised
≥1 bacteria*
n (%)95% CIn (%)95% CIn (%)95% CIn (%)95% CIn (%)95% CI
National (n=5117) 4 (0.1%)0.0% to 0.2%16 (0.3%)0.2% to 0.5%21 (0.4%)0.3% to 0.6%230 (4.5%)3.9% to 5.1% 266 (5.2%) 4.6% to 5.8%
Type of area
 University hospitals (n=2203)4 (0.2%)0.0% to 0.5%6 (0.3%)0.1% to 0.6%9 (0.4%)0.2% to 0.8%101 (4.5%)3.7% to 5.5%116 (5.3%)4.4% to 6.3%
 Regional hospitals (n=2914)0 (0%)0% to 0.1%10 (0.3%)0.2% to 0.6%12 (0.4%)0.2% to 0.7%129 (4.4%)3.7% to 5.2%150 (5.1%)4.3% to 6.0%
Region
 North Denmark (n=1055)1 (0.1%)0.0% to 0.5%0 (0%)0% to 0.3%2 (0.2%)0.0% to 0.7%39 (3.7%)2.6% to 5.0%41 (3.9%)2.8% to 5.2%
 Central Denmark (n=1376)0 (0%)0% to 0.2%12 (0.9%)0.5% to 1.5%10 (0.7%)0.3% to 1.3%71 (5.2%)4.1% to 6.5%91 (6.6%)5.4% to 8.1%
 Southern Denmark (n=1195)0 (0%)0% to 0.3%3 (0.3%)0.01% to 0.7%3 (0.3%)0.1% to 0.7%57 (4.8%)3.6% to 6.1%62 (5.2%)4.0% to 6.6%
 Zealand (n=1491)3 (0.2%)0.0% to 0.6%1 (0.1%)0.0% to 0.4%6 (0.4%)0.1% to 0.9%63 (4.2%)3.3% to 5.4%72 (4.8%)3.8% to 6.0%
Sex
 Female (n=2558)0 (0%)0% to 0.01%8 (0.3%)0.1% to 0.6%11 (0.4%)0.2% to 0.8%108 (4.2%)3.5% to 5.1%125 (4.9%)4.0% to 5.8%
 Male (n=2529)4 (0.2%)0.0% to 0.4%8 (0.3%)0.1% to 0.6%10 (0.4%)0.2% to 0.7%119 (4.7%)3.9% to 5.6%138 (5.5%)4.6% to 6.4%
Age (years)
 18–49 (n=966)0 (0%)0% to 0.4%2 (0.2%)0.0% to 0.7%0 (0%)0% to 0.4%45 (4.7%)3.4% to 6.2%47 (4.9%)3.4% to 6.4%
 50–64 (n=1207)1 (0.1%)0.0% to 0.5%4 (0.3%)0.1% to 0.8%2 (0.2%)0.0% to 0.6%65 (5.4%)4.2% to 6.8%70 (5.8%)4.5% to 7.3%
 65–79 (n=1903)1 (0.1%)0.0% to 0.3%7 (0.4%)0.1% to 0.7%10 (0.5%)0.3% to 1.0%86 (4.5%)3.6% to 5.6%104 (5.5%)4.5% to 6.6%
 >80 (n=1041)2 (0.2%)0.0% to 0.7%3 (0.3%)0.1% to 0.8%9 (0.9%)0.4% to 1.6%34 (3.3%)2.3% to 4.5%45 (4.3%)3.2% to 5.7%
  • *Five patients had >1 MRB, not included in the numbers.

  • CPE, carbapenemase-producing enterobacteria; ESBL, extended-spectrum beta-lactamase-producing enterobacteria; MRB, multiresistant bacteria; MRSA, methicillin-resistant Staphylococcus aureus; VRE, vancomycin-resistant enterococci.